Literature DB >> 19033877

Improved sensibility of the foot after temporary cutaneous anesthesia of the lower leg.

Birgitta Rosén1, Anders Björkman, Andreas Weibull, Jonas Svensson, Göran Lundborg.   

Abstract

Cutaneous anesthesia (EMLA_cream) of the forearm results in rapid improvement of hand sensibility, and here we applied this concept in the lower extremity. This double-blind study with 40 volunteers randomized to cutaneous application of anesthetic cream to the lower leg showed a significant improvement 2 h after treatment in touch thresholds in the EMLA group as compared with the placebo group. In 12 volunteers, fMRI examination was performed before and after treatment. Improvement was not associated with a visible cortical expansion of the cortical foot area. This novel finding may have considerable therapeutic potential in the treatment of foot sensibility disturbances in various neuropathies, such as diabetic neuropathy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19033877     DOI: 10.1097/WNR.0b013e32831b4486

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  3 in total

1.  Improving hand sensibility in vibration induced neuropathy: A case-series.

Authors:  Birgitta Rosén; Anders Björkman; Göran Lundborg
Journal:  J Occup Med Toxicol       Date:  2011-04-27       Impact factor: 2.646

2.  Principles of brain plasticity in improving sensorimotor function of the knee and leg in healthy subjects: a double-blind randomized exploratory trial.

Authors:  Eva Ageberg; Anders Björkman; Birgitta Rosén; Göran Lundborg; Ewa M Roos
Journal:  BMC Musculoskelet Disord       Date:  2009-08-05       Impact factor: 2.362

3.  Principles of brain plasticity in improving sensorimotor function of the knee and leg in patients with anterior cruciate ligament injury: a double-blind randomized exploratory trial.

Authors:  Eva Ageberg; Anders Björkman; Birgitta Rosén; Ewa M Roos
Journal:  BMC Musculoskelet Disord       Date:  2012-05-10       Impact factor: 2.362

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.